BOSTON–(BUSINESS WIRE)–PureTech Announces Presentation of Phase 1b Results for LYT-200 in R/R High-Risk Myelodysplastic Syndromes & Acute Myeloid Leukemia at ESMO 2026
BOSTON–(BUSINESS WIRE)–PureTech Announces Presentation of Phase 1b Results for LYT-200 in R/R High-Risk Myelodysplastic Syndromes & Acute Myeloid Leukemia at ESMO 2026